IP Library Granted Patent US 12,213,842
Granted Patent B2
US 12,213,842 · App. 18/188,761 · Granted Feb 4, 2025

Apparatus for preventing device deployment failure

Inventors: Kevin Alexander Lessard (San Francisco, CA); Christopher Zaler (Los Gatos, CA); Jolene Cutts (San Francisco, CA); Alexander Charles Gordon (San Carlos, CA); Maheshwara Rao (Oakland, CA); Mitchell C. Barham (San Mateo, CA)
Assignee: Teleflex Life Sciences LLC
A61B90/03A61B17/00234A61B17/0401A61B17/0469A61B17/06A61B90/08A61B2017/00274A61B2090/034A61B2090/0811
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,213,842
App. No.
18/188,761
Granted
Feb 4, 2025
Kind
B2
Abstract

An apparatus for preventing deployment failure or damage of a movable portion of a treatment device via a force limiting element in the treatment device.

Claims (28)

1. An apparatus for manipulating tissue within a subject to treat a medical condition, the apparatus comprising:

a first movable assembly coupled to a needle;

a second movable assembly coupled to a suturing component, wherein the first movable assembly and the second movable assembly are configured to move relative to each other;

a force limiting element coupled to the second movable assembly and a proximal portion of the suturing component, wherein the force limiting element is configured to maintain a position of the second movable assembly relative to the first movable assembly; and

an implant configured for deployment within the tissue, the implant comprising one or more anchor members connected to a tensioning element.

2. The apparatus of claim 1 , wherein the suturing component comprises an elongate tubular member defining an inner lumen configured to accommodate a suture.

3. The apparatus of claim 1 , wherein the first movable assembly is configured to move proximally relative to the second movable assembly.

4. The apparatus of claim 1 , wherein the force limiting element comprises a spring.

5. The apparatus of claim 4 , wherein a portion of the suturing component is configured to extend through a lumen defined by coils of the spring.

6. The apparatus of claim 4 , wherein the spring is a tension spring configured to extend in response to an increase in frictional force received at a distal end of the needle.

7. The apparatus of claim 1 , wherein the force limiting element comprises a latch configured to reversibly couple with a complementary notch defined by the second movable assembly.

8. The apparatus of claim 7 , wherein the latch is configured to disengage from the notch in response to an increase in frictional force received at a distal end of the needle.

9. The apparatus of claim 1 , wherein manipulating comprises retracting, lifting, compressing, displacing, approximating, supporting, remodeling, repositioning, ablating, or altering at least a portion of the tissue.

10. The apparatus of claim 1 , wherein the tissue comprises a prostate gland.

11. The apparatus of claim 1 , wherein a portion of the suturing component extends through a passage defined by the second movable assembly.

12. The apparatus of claim 11 , further comprising a friction element configured to conditionally prevent the suturing component from moving proximally through the passage.

13. The apparatus of claim 12 , wherein a cross section of the suturing component is greatest at the friction element.

14. A cartridge for delivering an implant, comprising:

a housing;

a movable assembly positioned within the housing and coupled to a suturing component, the suturing component comprising a suture and an elongate tubular member defining an inner lumen configured to accommodate the suture, wherein the movable assembly is configured to move relative to the housing; and

a force limiting element coupled to the movable assembly and a proximal portion of the suturing component, the force limiting element configured to absorb frictional forces received at a distal portion of the suturing component during delivery of the implant to a tissue.

15. The cartridge of claim 14 , wherein the force limiting element comprises a latch configured to reversibly couple with a complementary notch defined by the movable assembly.

16. The cartridge of claim 14 , wherein the force limiting element comprises a spring.

17. The cartridge of claim 14 , further comprising a needle and an elongate assembly, wherein the needle is configured to slide longitudinally through the elongate assembly during delivery of the implant.

18. An apparatus for manipulating tissue within a subject to treat a medical condition, the apparatus comprising:

a first movable assembly coupled to a needle;

a second movable assembly coupled to a suturing component, wherein the first movable assembly and the second movable assembly are configured to move relative to each other;

a force limiting element coupled to the second movable assembly and a proximal portion of the suturing component, wherein the force limiting element is configured to maintain a position of the second movable assembly relative to the first movable assembly, wherein the force limiting element comprises a spring, and a portion of the suturing component is configured to extend through a lumen defined by coils of the spring.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066617/0582 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066621/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066305/0073 →
MERGER Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066305/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2023
From: LESSARD, KEVIN ALEXANDER; ZALER, CHRISTOPHER; CUTTS, JOLENE; GORDON, ALEXANDER CHARLES; RAO, MAHESHWARA; BARHAM, MITCHELL C.
To: NEOTRACT, INC.
Reel/Frame 063077/0252 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2023
From: NEOTRACT, INC.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 063149/0462 →
Continuity (3)
Continuation 17178679 · Feb 18, 2021
Provisional Application 62979903 · Feb 21, 2020
Related Publication 20230218362A1 · Jul 13, 2023
References Cited (118)
US 4896678A · Ogawa · 1990 [cited by applicant]
US 5499994A · Tihon et al. · 1996 [cited by applicant]
US 5897564A · Schulze et al. · 1999 [cited by applicant]
US 6068624A · Benecke et al. · 2000 [cited by applicant]
US 7645286B2 · Catanese et al. · 2010 [cited by applicant]
US 7758594B2 · Lamson et al. · 2010 [cited by applicant]
US 7766923B2 · Catanese et al. · 2010 [cited by applicant]
US 7905889B2 · Catanese et al. · 2011 [cited by applicant]
US 7938046B2 · Nino et al. · 2011 [cited by applicant]
US 7951158B2 · Catanese et al. · 2011 [cited by applicant]
US 8007503B2 · Catanese et al. · 2011 [cited by applicant]
US 8157815B2 · Catanese et al. · 2012 [cited by applicant]
US 8216254B2 · McLean et al. · 2012 [cited by applicant]
US 8333776B2 · Cheng et al. · 2012 [cited by applicant]
US 8343187B2 · Lamson et al. · 2013 [cited by applicant]
US 8394110B2 · Catanese et al. · 2013 [cited by applicant]
US 8425535B2 · McLean et al. · 2013 [cited by applicant]
US 8663243B2 · Lamson et al. · 2014 [cited by applicant]
US 8715239B2 · Lamson et al. · 2014 [cited by applicant]
US 8715298B2 · Catanese et al. · 2014 [cited by applicant]
US 8900252B2 · Lamson et al. · 2014 [cited by applicant]
US 8936609B2 · Catanese et al. · 2015 [cited by applicant]
US 8939996B2 · Cheng et al. · 2015 [cited by applicant]
US 9320511B2 · McLean et al. · 2016 [cited by applicant]
US 9549739B2 · Catanese et al. · 2017 [cited by applicant]
US 9931192B2 · McLean et al. · 2018 [cited by applicant]
US 10105132B2 · Amson et al. · 2018 [cited by applicant]
US 10299780B2 · Catanese et al. · 2019 [cited by applicant]
US 10702261B2 · Stiggelbout · 2020 [cited by applicant]
US 11701197B2 · Lessard · 2023 [cited by examiner]
US 20030229263A1 · Connors et al. · 2003 [cited by applicant]
US 20040181235A1 · Daignault et al. · 2004 [cited by applicant]
US 20050256530A1 · Petros · 2005 [cited by applicant]
US 20060195008A1 · Whalen et al. · 2006 [cited by applicant]
US 20070260257A1 · Phan · 2007 [cited by applicant]
US 20080262424A1 · Hooft · 2008 [cited by applicant]
US 20090112234A1 · Crainich et al. · 2009 [cited by applicant]
US 20100063351A1 · Witzmann et al. · 2010 [cited by applicant]
US 20100191045A1 · Gobron et al. · 2010 [cited by applicant]
US 20100256442A1 · Ogdahl et al. · 2010 [cited by applicant]
US 20100261950A1 · Und et al. · 2010 [cited by applicant]
US 20100286717A1 · Heinrich et al. · 2010 [cited by applicant]
US 20100298831A1 · Browne et al. · 2010 [cited by applicant]
US 20110024145A1 · Click et al. · 2011 [cited by applicant]
US 20110082471A1 · Holcomb et al. · 2011 [cited by applicant]
US 20110105841A1 · Kutikov et al. · 2011 [cited by applicant]
US 20110172755A1 · Nelson et al. · 2011 [cited by applicant]
US 20110276081A1 · Kilemnik · 2011 [cited by applicant]
US 20120041533A1 · Bertolino et al. · 2012 [cited by applicant]
US 20120041534A1 · Clerc et al. · 2012 [cited by applicant]
US 20120245600A1 · McLean et al. · 2012 [cited by applicant]
US 20120265006A1 · Makower et al. · 2012 [cited by applicant]
US 20130046338A1 · Suzuki et al. · 2013 [cited by applicant]
US 20130268001A1 · Catanese et al. · 2013 [cited by applicant]
US 20130296889A1 · Tong et al. · 2013 [cited by applicant]
US 20140005473A1 · Catanese et al. · 2014 [cited by applicant]
US 20140031835A1 · Viker et al. · 2014 [cited by applicant]
US 20140180067A1 · Stigall et al. · 2014 [cited by applicant]
US 20140275756A1 · Bender et al. · 2014 [cited by applicant]
US 20140296881A1 · Ranucci et al. · 2014 [cited by applicant]
US 20150025652A1 · McLean et al. · 2015 [cited by applicant]
US 20150127050A1 · Lamson et al. · 2015 [cited by applicant]
US 20150351743A1 · Stiggelbout · 2015 [cited by applicant]
US 20160022265A1 · Kawaura et al. · 2016 [cited by applicant]
US 20160045297A1 · Siegel et al. · 2016 [cited by applicant]
US 20160095685A1 · Vemuri et al. · 2016 [cited by applicant]
US 20170000598A1 · Bachar · 2017 [cited by applicant]
US 20170112489A1 · Shelton, IV et al. · 2017 [cited by applicant]
US 20170135830A1 · Harkin et al. · 2017 [cited by applicant]
US 20170156723A1 · Keating et al. · 2017 [cited by applicant]
US 20170367748A1 · Plotkin · 2017 [cited by applicant]
US 20180049816A1 · Shelton, IV et al. · 2018 [cited by applicant]
US 20180103945A1 · Ciulla et al. · 2018 [cited by applicant]
US 20180318114A1 · Huang et al. · 2018 [cited by applicant]
US 20190125334A1 · Tong et al. · 2019 [cited by applicant]
US 20190365362A1 · Ralph · 2019 [cited by applicant]
US 20200038213A1 · Bly et al. · 2020 [cited by applicant]
US 20200121442A1 · Askeland · 2020 [cited by applicant]
US 20210145619A1 · Bly et al. · 2021 [cited by applicant]
US 20210161641A1 · Bachar · 2021 [cited by applicant]
US 20210161642A1 · Jen et al. · 2021 [cited by applicant]
US 20210259799A1 · Lessard et al. · 2021 [cited by applicant]
US 20210307641A1 · Rumbles et al. · 2021 [cited by applicant]
US 20220000445A1 · Datta et al. · 2022 [cited by applicant]
US 20220024145A1 · Itsuno et al. · 2022 [cited by applicant]
US 20220031357A1 · Cutts et al. · 2022 [cited by applicant]
US 20220031358A1 · Yarra et al. · 2022 [cited by applicant]
US 20220031389A1 · Fischell et al. · 2022 [cited by applicant]
US 20220061834A1 · Chung et al. · 2022 [cited by applicant]
US 20220125499A1 · Hoey et al. · 2022 [cited by applicant]
US 20220133462A1 · Kilemnik · 2022 [cited by applicant]
US 20220142464A1 · Petroff et al. · 2022 [cited by applicant]
US 20220240925A1 · Epstein et al. · 2022 [cited by applicant]
US 20220249219A1 · Chung et al. · 2022 [cited by applicant]
US 20220265262A1 · Melsheimer · 2022 [cited by applicant]
US 20220273918A1 · Ghriallais et al. · 2022 [cited by applicant]
US 20220378577A1 · Anderson et al. · 2022 [cited by applicant]
US 20220395363A1 · Ghriallais et al. · 2022 [cited by applicant]
US 20230022482A1 · Dhavale · 2023 [cited by applicant]
CN 105852938A · 2016 [cited by applicant]
CN 109675177A · 2019 [cited by applicant]
CN 211156119U · 2020 [cited by applicant]
CN 112891032A · 2021 [cited by applicant]
CN 216221843U · 2022 [cited by applicant]
DE 102019101987A1 · 2020 [cited by applicant]
JP 63147449 · 1988 [cited by applicant]
JP 2008093437A · 2008 [cited by applicant]
JP 2013517899A · 2013 [cited by applicant]
JP 2023502729A · 2023 [cited by applicant]
KR 101534820B1 · 2015 [cited by applicant]
WO 2011094299A3 · 2011 [cited by applicant]
WO 2012028843A1 · 2012 [cited by applicant]
WO 2012118011A1 · 2012 [cited by applicant]
WO 2017026167A1 · 2017 [cited by applicant]
WO 2021190092A1 · 2021 [cited by applicant]
Office Action mailed Feb. 22, 2023, in Japanese Patent Appln. 2022-522645. [cited by applicant]
PCT International Search Report mailed Jun. 9, 2021 in PCT application No. PCT/US2021/018487. [cited by applicant]
PCT Written Opinion mailed Jun. 9, 2021 in PCT application No. PCT/US2021/018487. [cited by applicant]